BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 12637894)

  • 1. Drug-eluting stents.
    Med Lett Drugs Ther; 2003 Mar; 45(1152):23-4. PubMed ID: 12637894
    [No Abstract]   [Full Text] [Related]  

  • 2. Outcome in the real-world of coronary high-risk intervention with drug-eluting stents (ORCHID) -- a single-center study comparing Cypher sirolimus-eluting with Taxus paclitaxel-eluting stents.
    Kumar S; Suresh V; Prendergast BD; Brooks NH; Wicks P; Levy RD; Ray SG; Bennett DH; Lee HS
    Catheter Cardiovasc Interv; 2006 Nov; 68(5):663-8. PubMed ID: 17034063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-eluting stents for the prevention of restenosis: Standing the test of time.
    Carter AJ
    Catheter Cardiovasc Interv; 2002 Sep; 57(1):69-71. PubMed ID: 12203932
    [No Abstract]   [Full Text] [Related]  

  • 4. [Drug eluting stents--end of restenosis?].
    Groch L
    Vnitr Lek; 2004 Oct; 50 Suppl 1():S59-62. PubMed ID: 15651142
    [No Abstract]   [Full Text] [Related]  

  • 5. Choosing a drug-eluting stent: a comparison between CYPHER and TAXUS.
    Perin EC
    Rev Cardiovasc Med; 2005; 6 Suppl 1():S13-21. PubMed ID: 15665793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-eluting coronary stents: many meta-analyses, little benefit.
    Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized trial versus registry data--comparing apples and ORCHIDs.
    Moliterno DJ
    Catheter Cardiovasc Interv; 2006 Nov; 68(5):669-70. PubMed ID: 17039505
    [No Abstract]   [Full Text] [Related]  

  • 8. Restenosis in percutaneous coronary intervention--is drug-eluting stent the answer?
    Lim VY; Lim YL
    Singapore Med J; 2003 Sep; 44(9):482-7. PubMed ID: 14740779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The paclitaxel-eluting stent in percutaneous coronary intervention: Part II. Comparison with the sirolimus-eluting stent, economics, and unanswered questions.
    Ray GM; Nawarskas JJ; Frishman WH
    Cardiol Rev; 2006; 14(3):143-50. PubMed ID: 16628023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-eluting stents.
    García-García HM; Vaina S; Tsuchida K; Serruys PW
    Arch Cardiol Mex; 2006; 76(3):297-319. PubMed ID: 17091802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-eluting stents for the treatment of in-stent restenosis: a clinical review.
    Yan BP; Ajani AE; Waksman R
    Cardiovasc Revasc Med; 2005; 6(1):38-43. PubMed ID: 16263355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Drug-eluting or bare-metal stents in interventional cardiology. Theory and practice].
    Er F; Erdmann E
    Med Klin (Munich); 2007 Jan; 102(1):30-2. PubMed ID: 17221349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The sirolimus coated stent: will the Achilles heel of interventional cardiology finally be cured?
    Beyar R; Roguin A
    Eur Heart J; 2001 Nov; 22(22):2054-7. PubMed ID: 11686663
    [No Abstract]   [Full Text] [Related]  

  • 14. Very late [corrected] thrombosis of a sirolimus-eluting stent.
    Henderson D; Gunalingam B
    Catheter Cardiovasc Interv; 2006 Sep; 68(3):406-8. PubMed ID: 16892439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is sirolimus better than paclitaxel? A review of the comparative data on drug-eluting stents.
    Corbett SJ; Babic R; Cosgrave J; Sangiorgi GM; Colombo A
    Cardiovasc Revasc Med; 2006; 7(3):159-64. PubMed ID: 16945823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-eluting stents: the panacea for restenosis?
    Lim MC
    Singapore Med J; 2004 Jul; 45(7):300-2. PubMed ID: 15221043
    [No Abstract]   [Full Text] [Related]  

  • 17. Early experiences and clinical implications of restenosis and drug-eluting stents: Part 2.
    Chong PH; Cheng JW
    Ann Pharmacother; 2004 May; 38(5):845-52. PubMed ID: 15039482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Release profiles in drug-eluting stents: issues and uncertainties.
    Venkatraman S; Boey F
    J Control Release; 2007 Jul; 120(3):149-60. PubMed ID: 17582635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New drug-eluting stents, optimizing technique, and the problem of drug-eluting stent restenosis.
    Vaina S; Ong AT; Serruys PW
    Minerva Cardioangiol; 2005 Oct; 53(5):341-60. PubMed ID: 16179880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Editorial comment: which is the preferred drug-eluting stent?
    Brodie BR
    J Interv Cardiol; 2006 Feb; 19(1):39-42. PubMed ID: 16483338
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.